CHEMBIO DIAGNOSTICS, INC. - 163572209
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2023
· Q4 2022
Value (USD)
Total reported value ($000)
$1.064M
QoQ value delta ($000)
+$498K
(+87.99%)
Implied price effect (QoQ)
+100.55%
Shares
Total shares
2,420,461
QoQ shares delta
-161,730
(-6.26%)
Total shares held by funds (by quarter)
Top holders (Q1 2023)
Top 25 only
Full list
Early Q2 2023 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 690 | 1,561,470 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 123 | 279,456 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 69 | 157,100 | 0.0% |
| Bank of New York Mellon Corp | 54 | 123,045 | 0.0% |
| NORTHERN TRUST CORP | 35 | 81,124 | 0.0% |
| SIGNATUREFD, LLC | 28 | 64,700 | 0.0% |
| STATE STREET CORP | 23 | 53,409 | 0.0% |
| JANE STREET GROUP, LLC | 15 | 35,646 | 0.0% |
| CITADEL ADVISORS LLC | 11 | 25,909 | 0.0% |
| UBS Group AG | 8 | 18,681 | 0.0% |
| Tower Research Capital LLC (TRC) | 4 | 9,810 | 0.0% |
| IFP Advisors, Inc | 3 | 375 | 0.0% |
| JPMORGAN CHASE & CO | 1 | 1,493 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 2,250 | 0.0% |
| HARBOUR INVESTMENTS, INC. | 0 | 250 | 0.0% |
| MORGAN STANLEY | 0 | 1,497 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 270 | 0.0% |
| WHITTIER TRUST CO | 0 | 625 | 0.0% |
| BNP PARIBAS ARBITRAGE, SNC | 0 | 165 | 0.0% |
| SIMPLEX TRADING, LLC | 0 | 2,036 | 0.0% |
| ADVISOR GROUP HOLDINGS, INC. | 0 | 1,150 | 0.0% |